Macular degeneration and related diseases
$2,300 guaranteed award | $4,600 maximum award
Get notified when openHelp with healthcare costs for macular degeneration and related diseases
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for macular degeneration and related diseases, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have government-insured coverage that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Alymsys (Bevacizumab-Maly)
- Avastin (Bevacizumab)
- Avzivi (Bevacizumab)
- Beovu (Brolucizumab-Dbll)
- Byooviz (Ranibizumab-Nuna)
- Cimerli (Ranibizumab-Eqrn)
- Encelto (Revakinagene Taroretcel-Lwey)
- Eylea (Aflibercept)
- Eylea HD (Aflibercept)
- Iluvien (Fluocinolone Acetonide)
- Izervay (Avacincaptad Pegol Sodium)
- Jobevne (Bevacizumab-Nwgd)
- Lucentis (Ranibizumab)
- Mvasi (Bevacizumab-Awwb)
- Ozurdex (Dexamethasone)
- Pavblu (Aflibercept-Ayyh)
- Retisert (Fluocinolone Acetonide)
- Susvimo (Ocular Implant For Ranibizumab)
- Susvimo (Ranibizumab)
- Syfovre (Pegcetacoplan)
- Triesence (Triamcinolone Acetonide)
- Vabysmo (Faricimab-Svoa)
- Vegzelma (Bevacizumab-Adcd)
- Visudyne (Verteporfin)
- Xipere (Triamcinolone Acetonide)
- Yutiq (Fluocinolone Acetonide)
- Zirabev (Bevacizumab-Bvzr)
About the disease
Macular diseases are eye diseases that cause vision loss. They are chronic diseases that affect the nervous system. Subtypes include age-related macular degeneration (all subtypes), macular edema, Stargardt disease, cystoid macular degeneration, drusen of macula, puckering of macula, and vitreomacular adhesion.
Diagnosis codes
E08.311, E08.3211, E08.3212, E08.3213, E08.3219, E08.3311, E08.3312, E08.3313, E08.3319, E08.3411, E08.3412, E08.3413, E08.3419, E08.3511, E08.3512, E08.3513, E08.3519, E08.3521,
E08.3522, E08.3523, E08.3529, E09.311, E09.3211, E09.3212, E09.3213, E09.3219, E09.3311, E09.3312, E09.3313, E09.3319, E09.3411, E09.3412, E09.3413, E09.3419, E09.3511, E09.3512, E09.3513, E09.3519, E09.3521, E09.3522, E09.3523, E09.3529, E10.311, E10.3211, E10.3212, E10.3213, E10.3219, E10.3311, E10.3312, E10.3313, E10.3319, E10.3411, E10.3412, E10.3413, E10.3419, E10.3511, E10.3512, E10.3513, E10.3519, E10.3521, E10.3522, E10.3523, E10.3529, E11.311, E11.3211, E11.3212, E11.3213, E11.3219, E11.3311, E11.3312, E11.3313, E11.3319, E11.3411, E11.3412, E11.3413, E11.3419, E11.3511, E11.3512, E11.3513, E11.3519, E11.3521, E11.3522, E11.3523, E11.3529, E13.3211, E13.3212, E13.3213, E13.3219, E13.3311, E13.3312, E13.3313, E13.3319, E13.3411, E13.3412, E13.3413, E13.3419, E13.3511, E13.3512, E13.3513, E13.3519, E13.3521, E13.3522, E13.3523, E13.3529, H35.30, H35.3110, H35.3111, H35.3112, H35.3113, H35.3114, H35.3120, H35.3121, H35.3122, H35.3123, H35.3124, H35.3130, H35.3131, H35.3132, H35.3133, H35.3134, H35.3190, H35.3191, H35.3192, H35.3193, H35.3194, H35.3210, H35.3211, H35.3212, H35.3213, H35.3220, H35.3221, H35.3222, H35.3223, H35.3230, H35.3231, H35.3232, H35.3233, H35.3290, H35.3291, H35.3292, H35.3293, H35.351, H35.352, H35.353, H35.359, H35.361, H35.362, H35.363, H35.369, H35.371, H35.372, H35.373, H35.379, H43.821, H43.822, H43.823, H43.829, H18.551, H18.552, H18.553, H18.559
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search helpHow does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn moreNeed help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Featured partner:
Prevent Blindness supports eye health and vision care through education, resources, and advocacy. They raise awareness about eye health, promote access to eye care, advocate for eye health policies and funding, support professional education and training, and empower individuals living with vision loss. The organization also provides free information and support for those at risk of or living with vision loss.
Get supportExplore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources



